• 25-Hydroxycholesterol Reprograms TAM Immunity

  2026-09-07

  Xiao et al. identify CH25H and lysosome-accumulated 25-hydroxycholesterol as an immunometabolic checkpoint that activates AMPKα and reinforces STAT6-dependent ARG1 production in tumor-associated macrophages. The study connects oxysterol compartmentalization with macrophage-mediated immune suppression and shows that targeting CH25H can improve antitumor immunity, including responses to anti-PD-1 therapy.

• Topotecan HCl Workflow for Cancer Assays

  2026-09-07

  Build more informative cancer-drug assays with Topotecan HCl by separating growth inhibition from actual cell killing. This workflow connects concentration and exposure schedules with orthogonal readouts for lung, breast, and prostate cancer models while highlighting practical formulation and troubleshooting decisions.

• Epigenetic Immune Signatures in Melanoma

  2026-09-05

  Anichini et al. compared five epigenetic drug classes and found that guadecitabine most consistently activated immune-related transcriptional programs in melanoma, including innate TLR, NF-κB, and interferon-associated pathways. The study links tumor-cell epigenetic remodeling with patient biopsy responses and provides a framework for selecting epigenetic partners for immune checkpoint blockade.

• BQCA and the Next Logic of M1 Signaling

  2026-09-04

  Benzyl Quinolone Carboxylic Acid (BQCA) offers a strategic way to study M1 muscarinic receptor signaling as a tunable, pathway-dependent process rather than a simple on/off response. This thought-leadership analysis connects BQCA’s pharmacology with GRK-regulated signaling bias, translational study design, and decision-making in cognitive and Alzheimer’s disease research.

• HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-09-04

  Build clearer fluorescence workflows for neuroblastoma nanocarrier studies with a spectrally defined goat anti-rabbit IgG secondary antibody. This guide connects immunocytochemistry, tissue imaging, flow cytometry, and ELISA readouts to the iRGD-modified red blood cell membrane photodynamic therapy model.

• Topotecan HCl and DNA Damage Burden

  2026-09-03

  Topotecan HCl is a topoisomerase 1 inhibitor that converts replication-associated lesions into actionable DNA damage signals. This article presents a cell-state and repair-capacity framework for interpreting its activity across cancer assays while carefully connecting those principles to new findings on selective CUX2 neuron loss in neuroinflammation.

• Gamma-linolenic Acid: Applied Research Workflows

  2026-09-03

  Build reproducible GLA experiments around lipid handling, LTB4-linked inflammatory assays, viability profiling, and disease-relevant cell models. The workflow also clarifies what can—and cannot—be inferred from new arachidonic acid vaccine-adjuvant findings.

• HRP Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-02

  HRP Goat Anti-Mouse IgG (H+L) Antibody, SKU K1221, provides an HRP-based detection layer for mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be treated as a universal secondary antibody for other host species, non-IgG mouse immunoglobulins, or fluorescence workflows without separate validation.

• EdU Imaging Kits (Cy3) for Locust Gut Studies

  2026-09-02

  EdU Imaging Kits (Cy3) convert DNA-replication activity into a bright Cy3 signal for microscopy or flow cytometry, enabling direct measurement of proliferating gut cells. The workflow complements RNAi and hormone-rescue experiments in Locusta migratoria by separating effects on S-phase entry from downstream tissue and molting phenotypes.

• Etomoxir A3404 for Reliable Metabolic Assays

  2026-09-01

  Learn how Etomoxir (SKU A3404) can improve interpretation of viability, proliferation, cytotoxicity, and immunometabolic assays by providing a defined CPT-1 perturbation. This scenario-based guide covers concentration selection, solvent handling, whole-blood compatibility, data interpretation, and practical product-selection criteria.

• Irinotecan Workflows for Colorectal Cancer Research

  2026-09-01

  Build more interpretable irinotecan experiments by separating prodrug activation, topoisomerase I–linked DNA damage, and downstream cell death. This workflow guide covers cell-based screening, xenograft translation, assay timing, solubility control, and troubleshooting for reproducible colorectal cancer research.

• Tiamulin (Thiamutilin): Mechanism & Use

  2026-08-31

  Tiamulin, also called Thiamutilin, is a semi-synthetic pleuromutilin antibiotic used mainly in pigs and poultry. It inhibits bacterial protein synthesis at the 50S ribosomal subunit and has separately reported anti-inflammatory activity, but dosing, residue control, and species-specific evidence remain essential.

• Prunin Targets Senecavirus A IRES-Dependent Replication

  2026-08-31

  The reference study reports that prunin suppresses Senecavirus A replication in cell culture and an animal model, with evidence implicating the viral internal ribosome entry site as a mechanistic target. Its main contribution is to connect an antiviral phenotype with a defined translation-control element, while also highlighting the need for orthogonal replication, toxicity, and in vivo validation.

• Macrophage Depletion as a Test of Liver Repair

  2026-08-30

  A translational framework for using Clodronate Liposomes to test whether macrophage states are causal drivers of hepatic ischemia-reperfusion injury, rather than merely correlates identified by single-cell analysis.

• Biomarkers Sharpen In Vitro Micronucleus Assays

  2026-08-29

  Avlasevich and colleagues combined flow-cytometric micronucleus scoring with DNA damage-response biomarkers to distinguish bona fide genotoxicity from irrelevant positive results associated with cytotoxicity. In a reference-chemical panel, requiring concordant micronucleus and biomarker responses markedly improved specificity while preserving sensitivity, creating a more informative framework for mode-of-action and potency assessment.

8462 records 1/565 page Next 12345 下5页 Last page